Cymulate
United States
- Dallas, Texas
- 06/09/2022
- Series D
- $70,000,000
For companies that want to manage their security posture against the evolving threat landscape: Cymulate SaaS-based Extended Security Posture Management (XSPM) deploys within an hour, enabling security professionals to continuously challenge, validate and optimize their cyber-security posture end-to-end across the MITRE ATT&CK® framework.
The platform provides out-of-the-box, expert, and threat intelligence-led risk assessments that are simple to deploy and use for all maturity levels, and constantly updated. It also provides an open framework to create and automate red and purple teaming by generating penetration scenarios and advanced attack campaigns tailored to their unique environments and security policies. Cymulate allows professionals to manage, know and control their dynamic environment.
- Industry Computer & Network Security
- Website https://cymulate.com/
- LinkedIn https://www.linkedin.com/company/cymulate/
Vector 👻 | $10,000,000 | (May 14, 2026)
Avant Genomics | $3,000,000 | (May 14, 2026)
Data Mission | $1,000,000 | (May 14, 2026)
Origin Lab | $8,000,000 | (May 14, 2026)
CREATE Medicines | $122,000,000 | (May 14, 2026)
Synthetic | $10,000,000 | (May 14, 2026)
SwishX | $2,200,000 | (May 14, 2026)
Dolfin | $2,460,580 | (May 14, 2026)
Urologic Health | $11,000,000 | (May 14, 2026)
Saile Medical (Saile App) | $2,200,000 | (May 14, 2026)
4AM | $4,000,000 | (May 13, 2026)
Adfin | $18,000,000 | (May 13, 2026)